Approvals/TGA/NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack

Approved

STANDARD

NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack

Mayne Pharma International Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: dad8dba7bf028fe6
Product Name: NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack
Artg Id: 341876
Artg Name: NEXTSTELLIS estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack
Sponsor: Mayne Pharma International Pty Ltd
Company Detail Path: /organization/mayne-pharma-international-pty-ltd
Artg Date: 2021-11-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/aa105f29283f43a714dee43a908dda8c.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4dbf99641e031393e5f3c0d9c1dfe678.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

dad8dba7bf028fe6

Type

Standard